397 related articles for article (PubMed ID: 22497716)
1. Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.
Kawabe S; Ito Y; Gotoh K; Kojima S; Matsumoto K; Kinoshita T; Iwata S; Nishiyama Y; Kimura H
Cancer Sci; 2012 Aug; 103(8):1481-8. PubMed ID: 22497716
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
3. Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases.
Kimura H; Miyake K; Yamauchi Y; Nishiyama K; Iwata S; Iwatsuki K; Gotoh K; Kojima S; Ito Y; Nishiyama Y
J Infect Dis; 2009 Oct; 200(7):1078-87. PubMed ID: 19698076
[TBL] [Abstract][Full Text] [Related]
4. Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection.
Fournier B; Boutboul D; Bruneau J; Miot C; Boulanger C; Malphettes M; Pellier I; Dunogué B; Terrier B; Suarez F; Blanche S; Castelle M; Winter S; Delecluse HJ; Molina T; Picard C; Ehl S; Moshous D; Galicier L; Barlogis V; Fischer A; Neven B; Latour S
J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32812031
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
[TBL] [Abstract][Full Text] [Related]
7. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
[TBL] [Abstract][Full Text] [Related]
9. Acquired hemophilia A associated with Epstein-Barr-virus-associated T/natural killer-cell lymphoproliferative disease: A case report.
Yamamoto M; Shindo M; Sumi C; Igarashi S; Saito T; Tsukada N; Toki Y; Hatayama M; Inamura J; Sato K; Mizukami Y; Torimoto Y; Okumura T
Medicine (Baltimore); 2021 Apr; 100(16):e25518. PubMed ID: 33879690
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic features of systemic EBV-positive T/NK-cell lymphoproliferative disease in adults].
Zheng XD; Zhou XG; Jin Y; Xie JL; Wei XJ; Chen SY; Mei X; Gong LP; Lü BB
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):227-34. PubMed ID: 21615995
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
[TBL] [Abstract][Full Text] [Related]
12. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.
Kimura H; Ito Y; Kawabe S; Gotoh K; Takahashi Y; Kojima S; Naoe T; Esaki S; Kikuta A; Sawada A; Kawa K; Ohshima K; Nakamura S
Blood; 2012 Jan; 119(3):673-86. PubMed ID: 22096243
[TBL] [Abstract][Full Text] [Related]
13. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.
Sawada A; Sato E; Koyama M; Higuchi B; Kusuki S; Kim JY; Takeshita Y; Sakata A; Sakata N; Okamura T; Yasui M; Inoue M; Kawa K
Am J Hematol; 2006 Aug; 81(8):576-81. PubMed ID: 16823820
[TBL] [Abstract][Full Text] [Related]
14. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic features of systemic EBV-positive T-cell lymphoproliferative disease of childhood].
Jin Y; Zhou XG; He LJ; Xie JL; Zheng YY; Zhang YN; Zhang SH
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):600-8. PubMed ID: 20079188
[TBL] [Abstract][Full Text] [Related]
16. An adult case of systemic Epstein-Barr virus-positive T/natural killer-cell lymphoproliferative disorder with good outcome.
Zhang X; Wang Z; Wang L; Yao H
Int J Clin Exp Pathol; 2013; 6(11):2620-4. PubMed ID: 24228130
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features and laboratory findings of adult Epstein-Barr virus associated T/NK lymphoproliferative disease].
Zhang Q; Zhang HY; Zhang WL; Zhong FL; Feng J; Meng QX; Yin WH; Nie LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):953-7. PubMed ID: 23998592
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
[TBL] [Abstract][Full Text] [Related]
19. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK;
Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
[Next] [New Search]
